Vernix caseosa is a cream-like substance secreted by the skin of a fetus in the womb. It is composed of fatty white or yellowish-white sebum, lanugo (fetal hair), and cellular debris from epidermal skin cells. It is thought to provide protection from the amniotic fluid, and promotes the transition to life outside the womb by increasing hydration of the skin, regulating skin temperature, providing antimicrobial protection, and aiding in desquamation of the fetal skin. Vernix caseosa is most prominent around the time of birth, especially in premature infants. It can be observed covering the face or scalp or increases of the body, like the neck, underarms, and hands. As babies age, it will start to disappear, typically after day 2 to 5 after birth. It has been described as appearing cheese-like due to its composition, but may vary in texture, from a thick paste to a slimy material. It can also vary in color from white to yellow-brown, though bloodstains may give it a reddish hue. There are several areas of research into the role and function of vernix caseosa, including its role in preventing UVC-induced neonatal skin damage, as well as its use in alleviating symptoms of certain dermatological conditions. There have been several studies that suggest vernix caseosa has antimicrobial properties that help protect the skin from infection and inflammation. The primary role of vernix caseosa is to ensure neonatal skin hydration, regulation of temperature, and a protective function to baby from environmental hazards, particularly ultraviolet (UV) radiation. Its role in promoting desquamation of the fetal skin has been the subject of much research as well. Additionally, there is evidence that suggests vernix caseosa may be effective in treating skin disorder and diseases, such as eczema, psoriasis, and atopic dermatitis. All in all, vernix caseosa plays a vital role in providing the newborn with optimal physiological and protective advantages as they transition from life in the womb to life outside the womb.
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Global perspectives on skin health: Diversity in dermatology and cosmetology
Dave Ray, Dave Ray Enterprises., United States
Title : How to correct cosmetic procedures gone wrong
Bharti Magoo, Golden Touch Clinic, India
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : Efficacy and safety of rituximab versus pulse therapy in immunobullous disorders: A retrospective study
Ravi M Rathod, KMCRI, India
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Stem cells in dermatology and cosmetology
Makoto Senoo, Cell Exosome Therapeutics Inc, Japan
Title : Standards, education and application of special cosmetic treatments in cosmetology practice
Elizabeta Popova Ramova, University MIT Skopje, Macedonia, The Former Yugoslav Republic of